Consolidated Balance Sheets (Unaudited) (Parenthetical) - USD ($) $ in Millions	Sep. 30, 2026	Dec. 31, 2025
Cash and cash equivalents
Restricted cash	$ 166	$ 169
Accumulated depreciation and amortization	13,266	12,039
Other assets, reserves for credit losses	123	86
Liabilities
Long-term debt	$ 58,538	$ 56,387
Shareholders’ Equity
Preferred shares, par value (in dollars per share)	$ 1.667	$ 1.667
Preferred shares authorized (in shares)	20,000,000	20,000,000
Preferred shares, issued (in shares)	1,600	1,600
Preferred shares, outstanding (in shares)	1,600	1,600
Common shares, par value (in dollars per share)	$ 0.20	$ 0.20
Common shares, authorized (in shares)	3,600,000,000	3,600,000,000
Common shares, issued (in shares)	671,000,000	686,000,000
Common shares, outstanding (in shares)	671,000,000	686,000,000
Card Balances
Cash and cash equivalents
Financing receivables, gross	$ 221,074	$ 213,863
Allowance for credit losses	5,634	6,089
Other Loans
Cash and cash equivalents
Financing receivables, gross	12,079	10,928
Allowance for credit losses	335	323
Variable Interest Entity, Primary Beneficiary
Liabilities
Long-term debt	12,177	13,022
Variable Interest Entity, Primary Beneficiary | Card Balances
Cash and cash equivalents
Financing receivables, gross	32,063	33,378
Variable Interest Entity, Primary Beneficiary | Short-Term Investments
Cash and cash equivalents
Restricted cash	$ 72	$ 84